Once Daily Aminoglycoside Pharmacokinetics and Optimal Tobramycin Dosing in the Burn Population: A Prospective Study
Year: 2016
Type: dissertation
Abstract: Background. Once-daily aminoglycoside (ODA) dosing is not commonly recommended in burn patients due to altered pharmacokinetics (PK). The objective was to determine the ability of ODA dosing to achieve target concentrations in burn patients. Methods. A single dose of tobramycin 10 mg/kg was given to patients with a total burn surface area (TBSA)
Source: TSpace (University of Toronto)
Author: Colin Lee
Language: English
Subfield: Pharmacology (medical)
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2891529562
